Person:
Yang, Yanfei

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Yang

First Name

Yanfei

Name

Yang, Yanfei

Filters

20131

Settings

Author's Publications: search.filters.isAuthorOfPublication.c4092ec9-3721-4d1c-9c2e-f518b7cf271f

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Molecular MRI of Collagen to Diagnose and Stage Liver Fibrosis
    (Elsevier BV, 2013) Fuchs, Bryan; Wang, Huifang; Yang, Yanfei; Wei, Lan; Polasek, Miloslav; Schühle, Daniel T.; Lauwers, Gregory Y.; Parkar, Ashfaq; Sinskey, Anthony J.; Tanabe, Kenneth; Caravan, Peter
    Background & Aims The gold standard in assessing liver fibrosis is biopsy despite limitations like invasiveness and sampling error and complications including morbidity and mortality. Therefore, there is a major unmet medical need to quantify fibrosis non-invasively to facilitate early diagnosis of chronic liver disease and provide a means to monitor disease progression. The goal of this study was to evaluate the ability of several magnetic resonance imaging (MRI) techniques to stage liver fibrosis. Methods A gadolinium (Gd)-based MRI probe targeted to type I collagen (termed EP-3533) was utilized to non-invasively stage liver fibrosis in a carbon tetrachloride (CCl4) mouse model and the results were compared to other MRI techniques including relaxation times, diffusion, and magnetization transfer measurements. Results The most sensitive MR biomarker was the change in liver:muscle contrast to noise ratio (ΔCNR) after EP-3533 injection. We observed a strong positive linear correlation between ΔCNR and liver hydroxyproline (i.e. collagen) levels (r = 0.89) as well as ΔCNR and conventional Ishak fibrosis scoring. In addition, the area under the receiver operating curve (AUR0C) for distinguishing early (Ishak ⩽3) from late (Ishak ⩾4) fibrosis was 0.942 ± 0.052 (p <0.001). By comparison, other MRI techniques were not as sensitive to changes in fibrosis in this model. Conclusions We have developed an MRI technique using a collagen-specific probe for diagnosing and staging liver fibrosis, and validated it in the CCl4 mouse model. This approach should provide a better means to monitor disease progression in patients.